Advertisement

94. Kongreß pp 169-175 | Cite as

Spontanverlauf und Aktivitätsparameter

  • H. Goebell
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 94)

Zusammenfassung

Unter den chronisch entzündlichen Darmerkrankungen verstehen wir im folgenden die Colitis ulcerosa einschließlich der Proktitis und den Morbus Crohn. Bakteriell bedingte Darmentzündungen, entzündliche Reaktionen nach Bestrahlung, Ischämie des Darmes rechnen wir nicht dazu.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Best WR, Becktel JM, Singleton JW, Kern F (1976) Development of a Crohn’s disease activity index. Gastroenterology 70:439–444PubMedGoogle Scholar
  2. 2.
    Brandes JW, Lorenz-Meyer H (1983) Epidemiologische Aspekte zur Enterocolitis regionalis Crohn und Colitis ulcerosa in Marburg/Lahn (FRG) zwischen 1962 und 1975. Z Gastroenterol 21:69–78PubMedGoogle Scholar
  3. 3.
    Daiss W, Scheurlen M, Malchow H (1988) Development of the epidemiology of chronic inflammatory bowel disease in the county of Tübingen from 1970–1984. In: Goebell H, Peskar BM, Malchow H (eds) Inflammatory bowel diseases. Falk-Symposium 46. MTP-Press, Lancaster, p 390Google Scholar
  4. 4.
    De Dombal FT, Softley A (1987). IOIBD report No. 1: Observer variation in calculating indices of severity and activity in Crohn’s disease. Gut 28:474–481PubMedCrossRefGoogle Scholar
  5. 5.
    Farmer RG (1988) Natural course of Crohn’s disease. In: Goebell H, Peskar BM, Malchow H (eds) Inflammatory bowel diseases. Falk-Symposium 46. MTP-Press, Lancaster, pp 267–273Google Scholar
  6. 6.
    Goebell H, Förster S, Dirks E, Hotz J, Schaarschmidt K, Eigler FW (1987) Morbus Crohn: Klinische Erkrankungsmuster in Beziehung zur Lokalisation. Med Klin 82:1–8Google Scholar
  7. 7.
    Goebell H (1988) Different activity indices in Crohn’s disease and their possible role. In: Goebell H, Peskar BM, Malchow H (eds) Inflammatory bowel diseases. Falk-Symposium 46. MTP-Press, Lancaster, pp 253–258Google Scholar
  8. 8.
    Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H (1984) European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology 86:249–266PubMedGoogle Scholar
  9. 9.
    Mekjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK (1979a) Clinical features and natural history of Crohn’s disease. Gastroenterology 77:69–78Google Scholar
  10. 10.
    Mekjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM (1979b) National Cooperative Crohn’s Disease Study: factors determining recurrence of Crohn’s disease after surgery. Gastroenterology 77:907–913Google Scholar
  11. 11.
    Peña AS, Weterman IT, Booth CC, Stober W (eds) (1981) Recent advances in Crohn’s disease. Developments in Gastroenterology, vol. 1. Martinus Nijhoff, The Hague, pp 151–184Google Scholar
  12. 12.
    Ritchie JK, Powell-Tuck J, Lennard-Jones JE (1978) Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet I:1140–1143 —CrossRefGoogle Scholar
  13. 13.
    Truelove SC (1983) Natural history of ulcerative colitis. In: Allan R, Keighley MRB, Alexander-Williams J, Hawkins C (eds) Churchill Livingstone, Edinburgh London, pp 94–100Google Scholar
  14. 14.
    Truelove SC, Witts LJ (1959) Cortisone and corticotrophin in ulcerative Colitis. Br Med J 1:387–394PubMedCrossRefGoogle Scholar
  15. 15.
    Van Hees PAM, Van Eiteren Ph, Van Lier HJJ, Van Tongeren JHM (1980) An index of inflammatory activity in patients with Crohn’s disease. Gut 21:279–286PubMedCrossRefGoogle Scholar

Copyright information

© J. F. Bergmann Verlag, München 1988

Authors and Affiliations

  • H. Goebell
    • 1
  1. 1.Medizinische Klinik und Poliklinik, Abteilung GastroenterologieUniversität EssenDeutschland

Personalised recommendations